May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Involvement of RhoA and neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA–induced neurotoxicity in the rat retina
Author Affiliations & Notes
  • Y. Kitaoka
    Dept of Ophthalmology,
    St. Marianna Univ. School of Medicine, Kawasaki–shi, Japan
    Ophthalmology, Doheny Eye Institute/USC, Los Angeles, CA
  • Y. Kitaoka
    Dept of Ophthalmology,
    St. Marianna Univ. School of Medicine, Kawasaki–shi, Japan
    Ophthalmology, Doheny Eye Institute/USC, Los Angeles, CA
  • T. Kumai
    Dept of Pharmacology,
    St. Marianna Univ. School of Medicine, Kawasaki–shi, Japan
  • T.T. Lam
    Ophthalmology, Doheny Eye Institute/USC, Los Angeles, CA
  • K. Kuribayashi
    Dept of Ophthalmology,
    St. Marianna Univ. School of Medicine, Kawasaki–shi, Japan
  • K. Isenoumi
    Dept of Ophthalmology,
    St. Marianna Univ. School of Medicine, Kawasaki–shi, Japan
  • Y. Munemasa
    Dept of Ophthalmology,
    St. Marianna Univ. School of Medicine, Kawasaki–shi, Japan
  • M. Motoki
    Dept of Ophthalmology,
    St. Marianna Univ. School of Medicine, Kawasaki–shi, Japan
  • S. Kobayashi
    Dept of Pharmacology,
    St. Marianna Univ. School of Medicine, Kawasaki–shi, Japan
  • S. Ueno
    Dept of Ophthalmology,
    St. Marianna Univ. School of Medicine, Kawasaki–shi, Japan
  • Footnotes
    Commercial Relationships  Y. Kitaoka, None; Y. Kitaoka, None; T. Kumai, None; T.T. Lam, None; K. Kuribayashi, None; K. Isenoumi, None; Y. Munemasa, None; M. Motoki, None; S. Kobayashi, None; S. Ueno, None.
  • Footnotes
    Support  Supported in part by NIH Core Grant EY03040 (DEI) and an unrestricted grant from RPB (DEI)
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 880. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Kitaoka, Y. Kitaoka, T. Kumai, T.T. Lam, K. Kuribayashi, K. Isenoumi, Y. Munemasa, M. Motoki, S. Kobayashi, S. Ueno; Involvement of RhoA and neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA–induced neurotoxicity in the rat retina . Invest. Ophthalmol. Vis. Sci. 2004;45(13):880.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: RhoA, a key protein involved in cytoskeleton regulation modulating neurogenesis, neural plasticity, has been implicated in a variety of cellular functions. We examined its involvement in N–methyl–d–aspartate (NMDA) induced–excitotoxicity in the retina, and evaluated the possible neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA–induced retinal neurotoxicity. Methods: Eight–week–old male Wistar rats were used as subjects. RhoA protein levels in NMDA–treated retina were assessed by Western blot analysis and were localized by immunohistochemistry. Fasudil (10–6 – 10–4 M together with 4 × 10–2 M NMDA) was given intravitreally. The number of cells in the ganglion cell layer (GCL) and the thickness of the inner plexiform layer (IPL), and retinal Thy–1 mRNA levels were evaluated at 5 days after injection. Results: Western blot analysis showed a transient increase of retinal RhoA protein 1 day after intravitreal NMDA injection, and that this increment was significantly prevented by simultaneous injection of fasudil. Immunohistochemistry showed that NMDA induced substantial increases in RhoA immunoreactivity in the GCL and the IPL. Fasudil injection reduced cell loss in the GCL and reduction in IPL thickness after NMDA injection. The reductions in Thy–1 mRNA levels by NMDA were also significantly attenuated by concomitant injection of fasudil. Conclusions: These results suggest that RhoA might be activated and involved in NMDA–induced retinal neurotoxicity, and that fasudil is neuroprotective against glutamate–related excitotoxicity.

Keywords: excitatory amino acid receptors • ganglion cells • neuroprotection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×